March 26, 2024 March 26, 2024Categories New TrialsNow Enrolling: ComboMATCH treatment trial E5 is testing a new option for patients with advanced solid tumors that have a KRAS G12C mutationThis study is assessing the combination of two drugs—sotorasib and panitumumab—in patients with KRAS G12C-mutated solid tumors
